DHI

DR Horton
D

DHI

Arincen52/100B
152.260
USD
-5.38
(-3.41%)
Market Closed
Last updated: · Delayed 15 min
Fair value104.64Plus+46%43Price 152.26158
Q1 FY2027 · Earnings report
EPS estimate 1.34Revenue estimate 6.07B
OverviewFinancialsForecastEarningsDividendsCompany

DR Horton net income 1992–2026

DR Horton earned 741.80M USD in Q4 FY2026, the three months to 30 September 2026, down 18.1% on the same quarter a year before. DR Horton's net income over the last twelve months was 2.89B USD, down 19.4% on the twelve months before. In fiscal year 2026 it earned 2.89B USD, down 19.4% on the year before.

Last updated 6 Nov 2026 · Next report 19 Jan 2027

Net income

Net income · +12.5% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20262.89B-19.41%8.74%33.04B
FY202630 Sept 20262.89B-19.41%8.74%33.04B
FY202530 Sept 20253.59B-24.62%10.47%34.25B
FY202430 Sept 20244.76B+0.23%12.92%36.80B
FY202330 Sept 20234.75B-18.98%13.38%35.46B
FY202230 Sept 20225.86B+40.27%17.50%33.48B
FY202130 Sept 20214.18B+75.92%15.03%27.77B
FY202030 Sept 20202.37B+46.66%11.69%20.31B
FY201930 Sept 20191.62B+10.83%9.20%17.59B
FY201830 Sept 20181.46B+40.63%9.09%16.07B
FY201730 Sept 20171.04B+17.16%7.37%14.09B
FY201630 Sept 2016886.30M+18.06%7.29%12.16B
FY201530 Sept 2015750.70M+40.71%6.94%10.82B
FY201430 Sept 2014533.50M+15.30%6.65%8.02B
FY201330 Sept 2013462.70M-51.62%7.39%6.26B
FY201230 Sept 2012956.30M+1,231.89%21.96%4.35B
FY201130 Sept 201171.80M-70.71%1.97%3.64B
FY201030 Sept 2010245.10M—5.57%4.40B
FY200930 Sept 2009-545.30M—-14.91%3.66B
FY200830 Sept 2008-2.63B—-39.63%6.65B
FY200730 Sept 2007-712.50M-157.77%-6.31%11.30B
FY200630 Sept 20061.23B-16.13%8.19%15.05B
FY200530 Sept 20051.47B+50.81%10.61%13.86B
FY200430 Sept 2004975.10M+55.78%8.99%10.84B
FY200330 Sept 2003625.96M+54.67%7.17%8.73B
FY200230 Sept 2002404.69M+57.46%6.01%6.74B
FY200130 Sept 2001257.01M+34.06%5.77%4.46B
FY200030 Sept 2000191.72M+19.97%5.25%3.65B
FY199930 Sept 1999159.80M+71.09%5.06%3.16B
FY199830 Sept 199893.40M+43.69%4.29%2.18B
FY199730 Sept 199765.00M+40.39%7.76%837.30M
FY199630 Sept 199646.30M+125.85%8.46%547.30M
FY199530 Sept 199520.50M+15.82%4.69%437.40M
FY199430 Sept 199417.70M+98.88%4.50%393.30M
FY199330 Sept 19938.90M-3.26%4.68%190.10M
FY199230 Sept 19929.20M—7.41%124.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about DR Horton's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.